CXCR4 and Miyoshi myopathy: Nevertheless, our study found nanoscale CXCR4-PEG-CdTe-DOX can significantly increase the drug concentration in the targeted MM cells (Fig. 4) [14, 17], thus reducing the toxic side effects on normal tissues.